Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA

J Leukoc Biol. 2012 Oct;92(4):775-85. doi: 10.1189/jlb.1011522. Epub 2012 Jul 2.

Abstract

Synthetic ODNs expressing CpG motifs trigger an innate immune response via TLR9. pDCs are major effectors of this response. Two structurally distinct classes of CpG ODNs have been identified that differentially activate pDCs. "K" ODNs trigger the production of TNF-α and IL-6, whereas "D" ODNs preferentially induce the secretion of IFN-α. As K and D ODNs have distinct therapeutic effects, knowledge of their shared and sequence-specific activity is of considerable importance. This work uses the CAL-1 human pDC line to analyze the effect of CpG stimulation on gene expression. Genes up-regulated by both K and D ODNs (n=92) were largely dependent on type I IFN signaling and characterized functionally by antiviral activity. K ODNs induced a short-term increase in IFN-α/β production and uniquely up-regulated genes that supported antibacterial responses. In contrast, D ODNs triggered a persistent increase in IFN-α/β production and uniquely up-regulated genes associated with metabolic functions. Thus, the core functionality of human pDCs mediated by TLR9 ligation rests on a type I IFN response that differs from the response induced by the structural elements unique to specific classes of ODNs.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Cells, Cultured
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology
  • Gene Expression Regulation / drug effects*
  • Humans
  • Interferon Type I / physiology*
  • Oligodeoxyribonucleotides / pharmacology*
  • STAT1 Transcription Factor / genetics
  • Toll-Like Receptor 9 / analysis
  • Toll-Like Receptor 9 / physiology

Substances

  • Adjuvants, Immunologic
  • CPG-oligonucleotide
  • Interferon Type I
  • Oligodeoxyribonucleotides
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • TLR9 protein, human
  • Toll-Like Receptor 9